Angela Walsh serves as Executive at Virios Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Angela Walsh has executed 2 insider transactions totaling $16.5K, demonstrating a bullish approach to their equity position. Their most recent transaction on May 23, 2022 involved purchasing 2,000 shares valued at $9.2K.
Angela Walsh currently holds 3,000 shares of Virios Therapeutics, Inc. (VIRI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Angela Walsh has been a net buyer of VIRI stock. They have purchased $16.5K and sold $0 worth of shares.
Angela Walsh's most recent insider trade was on May 23, 2022, when they purchased 2,000 shares at $4.58 per share.
Get notified when new Form 4 filings are submitted
| $7.30 |
| Discretionary |